Akero Therapeutics and CoreCard Corporation Under Investigation by Brodsky & Smith

Bala Cynwyd, Thursday, 9 October 2025.
Brodsky & Smith announced investigations into Akero Therapeutics and CoreCard Corporation on October 9, 2025, focusing on potential legal issues that could impact stock performance and investor confidence.